News
-
Revlimid PBS funded
Wednesday | Feb 1 2017REVLIMID (lenalidomide) is today listed on the Pharmaceutical Benefits Scheme (PBS) for newly diagnosed multiple myeloma patients ineligible for transplant.
-
Pharmacy key to dementia treatment
Wednesday | Feb 1 2017THE International Pharmaceutical Federation has stressed the importance of pharmaceutical science in developing national responses to dementia, in a presentation to the World Health Organization (WHO) board.
-
Ovarian cancer treatment onto PBS
Wednesday | Feb 1 2017ASTRAZENECA'S targeted cancer therapy Lynparza (olaparib) has been listed on the Pharmaceutical Benefits Scheme effective today, for the maintenance treatment of platinum-sensitive relapsed high-grade serious ovarian cancer (HGSOC) linked to the inherited BRCA gene mutation.
-
Permissibles update
Wednesday | Feb 1 2017AN UPDATED version of the Therapeutic Goods (Permissible Ingredients) Determination was registered on the Federal Register of Legislation last month.
-
CW takes a bath
Wednesday | Feb 1 2017ECOSTORE Australia has launched a new range of kids' bath products which are exclusively available through Chemist Warehouse.
-
Hep B vax storage fail
Wednesday | Feb 1 2017BABIES vaccinated for hepatitis B at Sydney's Bankstown-Lidcombe Hospital may have been given an ineffective dose, after a fridge used to store the routine vaccines was found to be too warm.
-
NZ pharmacist-GP pact
Wednesday | Feb 1 2017PHARMACISTS and doctors in New Zealand have together developed a new "person-centred framework," which would see both professions work together to deliver an integrated model of health care.
-
Dispensary Corner 31 Jan 17
Tuesday | Jan 31 2017THE Australian Reptile Park is encouraging brave members of the public to go out and catch deadly funnel-web spiders.
-
Probiotics update
Tuesday | Jan 31 2017AUSTRALIAN pharmacists will gain insight into the latest scientific evidence for potential benefits of probiotics to intestinal, skin, reproductive and immune health, with Dr Nigel Plummer added to the line-up of APP 2017 speakers.